{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:53:08Z","timestamp":1772754788883,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["AG044441-01A1"],"award-info":[{"award-number":["AG044441-01A1"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001077"],"award-info":[{"award-number":["KL2TR001077"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018556","name":"Voyager Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5 T32 GM007309"],"award-info":[{"award-number":["5 T32 GM007309"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.parkreldis.2021.01.019","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T08:12:24Z","timestamp":1611994344000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Attentional dysfunction and the punding spectrum in Parkinson's disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Jared T.","family":"Hinkle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Perepezko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Pontone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.01.019_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.01.019_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jagp.2019.03.002","article-title":"The neuropsychiatry of Parkinson disease: a perfect storm","volume":"27","author":"Weintraub","year":"2019","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.01.019_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.01.019_bib5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviors in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.01.019_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.01.019_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mds.23508","article-title":"The prevalence and clinical characteristics of punding in Parkinson's disease","volume":"26","author":"Spencer","year":"2011","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.parkreldis.2021.01.019_bib8","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/mds.21702","article-title":"Predictors of punding in Parkinson's disease: results from a questionnaire survey","volume":"22","author":"Lawrence","year":"2007","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.01.019_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson progression marker initiative (PPMI)","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.01.019_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib12","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib13","series-title":"A Language and Environment for Statistical Computing","author":"R Core Team","year":"2019"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.01.019_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.2018.6971","article-title":"Odds ratios-current best practice and use","volume":"320","author":"Norton","year":"2018","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib15","first-page":"1","article-title":"The R package geepack for generalized estimating equations","volume":"15\/2","author":"Halekoh","year":"2006","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.parkreldis.2021.01.019_bib16","series-title":"A Package for Survival Analysis in S","author":"Therneau","year":"2015"},{"key":"10.1016\/j.parkreldis.2021.01.019_bib17","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.parkreldis.2021.01.019_bib18","series-title":"Drawing Survival Curves Using 'ggplot2","author":"Kassambara","year":"2019"},{"key":"10.1016\/j.parkreldis.2021.01.019_bib19","article-title":"Clinical features associated with impulse control disorders in Parkinson's disease","volume":"21","author":"Pontone","year":"2006","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.01.019_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/mds.23061","article-title":"Punding in Parkinson's disease: the impact of patient's awareness on diagnosis","volume":"25","author":"Fasano","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.01.019_bib21","doi-asserted-by":"crossref","first-page":"E08","DOI":"10.1176\/appi.neuropsych.11120356","article-title":"Punding as a transient symptom in a patient with an early-onset form of dementia","volume":"25","author":"Oliveira","year":"2013","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.01.019_bib22","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.STR.0000260088.07611.6e","article-title":"Punding as a complication of brain stem stroke?: report of a case","volume":"38","author":"Nguyen","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.parkreldis.2021.01.019_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jns.2016.02.016","article-title":"Punding in non-demented Parkinson's disease patients: relationship with psychiatric and addiction spectrum comorbidity","volume":"362","author":"Pettorruso","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.01.019_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134468","article-title":"Patterns of neuropsychological profile and cortical thinning in Parkinson's disease with punding","volume":"10","author":"Yoo","year":"2015","journal-title":"PloS One"},{"issue":"23","key":"10.1016\/j.parkreldis.2021.01.019_bib25","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1212\/WNL.0000000000004012","article-title":"Role of habenula and amygdala dysfunction in Parkinson disease patients with punding","volume":"88","author":"Markovic","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.01.019_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2017.07.025","article-title":"White matter tract alterations in Parkinson's disease patients with punding","volume":"43","author":"Canu","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.01.019_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease","volume":"19","author":"Kurlan","year":"2004","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.01.019_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/mp.2009.95","article-title":"Insights into pathophysiology of punding reveal possible treatment strategies","volume":"15","author":"Fasano","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jns.2011.07.012","article-title":"Dopaminergic dysregulation syndrome in Parkinson's disease","volume":"310","author":"Katzenschlager","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.11.338","article-title":"Markers of impaired motor and cognitive volition in Parkinson's disease: correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias","volume":"47","author":"Hinkle","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.01.019_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ana.22097","article-title":"Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia","volume":"68","author":"Rylander","year":"2010","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.01.019_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/acn3.438","article-title":"Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study","volume":"4","author":"Brumberg","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:14:30Z","timestamp":1762370070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S1353802021000353"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.01.019","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attentional dysfunction and the punding spectrum in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}